OSTEOPOROSIS INTERNATIONAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588410, encodeId=3477588410cb, content=请问接收后多久出proof？139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！139JECX2951(暂无昵称) 2019-02-08 15:03:00 发表: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]

2021-08-01 ms1000000995331571

偏重的研究方向：骨质疏松
经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果

95 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588410, encodeId=3477588410cb, content=请问接收后多久出proof？139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！139JECX2951(暂无昵称) 2019-02-08 15:03:00 发表: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]

2022-02-09 ms6000000498436311

偏重的研究方向：骨质疏松
经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！

83 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588410, encodeId=3477588410cb, content=请问接收后多久出proof？139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！139JECX2951(暂无昵称) 2019-02-08 15:03:00 发表: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]

2021-12-29 rayms

所有作者在文章接收之后都会接收到邮件吗？

75 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588410, encodeId=3477588410cb, content=请问接收后多久出proof？139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！139JECX2951(暂无昵称) 2019-02-08 15:03:00 发表: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]

2022-06-03 ms1000001687207454

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：骨质疏松
经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。

67 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588410, encodeId=3477588410cb, content=请问接收后多久出proof？139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！139JECX2951(暂无昵称) 2019-02-08 15:03:00 发表: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]

2022-09-26 ms6000000510226862

2022年6月17日投稿，6月30日至今reviewers assigned

49 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588410, encodeId=3477588410cb, content=请问接收后多久出proof？139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！139JECX2951(暂无昵称) 2019-02-08 15:03:00 发表: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]

2019-02-08 1252754dm51(暂无昵称)

20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！

236 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588410, encodeId=3477588410cb, content=请问接收后多久出proof？139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！139JECX2951(暂无昵称) 2019-02-08 15:03:00 发表: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]

2021-08-08 798200815

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：内固定物;有限元分析
经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……

64 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588410, encodeId=3477588410cb, content=请问接收后多久出proof？139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！139JECX2951(暂无昵称) 2019-02-08 15:03:00 发表: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]

2021-04-15 798200815

偏重的研究方向：生物力学;有限元分析
经验分享：我今天凌晨投稿的。不知道要等到什么时候了。

59 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588410, encodeId=3477588410cb, content=请问接收后多久出proof？139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！139JECX2951(暂无昵称) 2019-02-08 15:03:00 发表: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]

2020-04-08 146ad228m80暂无昵称

请问接收后多久出proof？139JECX2951(暂无昵称) 2019-02-08 发表::
20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！139JECX2951(暂无昵称) 2019-02-08 15:03:00 发表:
20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！

139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！

191 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588410, encodeId=3477588410cb, content=请问接收后多久出proof？139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！139JECX2951(暂无昵称) 2019-02-08 15:03:00 发表: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=139JECX2951(暂无昵称) 2019-02-08 发表:: 20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]

2022-01-07 ms6000000498436311

偏重的研究方向：骨质疏松;筛查;成本效益分析
经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45.

44 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务